← Cardiovascular Disease Fellowship
Massachusetts General Hospital
Joseph ShinMD, PhD
MD · Johns Hopkins University School of Medicine
Residency · Johns Hopkins
Fellowship · Cardiovascular Disease Fellowship, Massachusetts General Hospital
publications
26
first author
9
median RCR
2.11
citations
1538
Publications
- 2025Longitudinal Evaluation of Genetic Hypertrophic Cardiomyopathy Penetrance and Transition to Disease in an Academic BiobankJACC Advancesfirst author3 citesPMID 39886308
- 2022Identification of the NRF2 transcriptional network as a therapeutic target for trigeminal neuropathic painScience AdvancesRCR 4.4244 citesPMID 35921423
- 2022Pharmacological TRPC6 inhibition improves survival and muscle function in mice with Duchenne muscular dystrophyJCI InsightRCR 1.9322 citesPMID 36099033
- 2021Radial versus femoral secondary access for transcatheter aortic valve replacement: A systematic review and meta‐analysisCatheterization and Cardiovascular InterventionsRCR 0.869 citesPMID 34792259
- 2020Study of Tofacitinib in Refractory Dermatomyositis: An Open‐Label Pilot Study of Ten PatientsArthritis & RheumatologyRCR 9.53130 citesPMID 33258553
- 2020TCT CONNECT-111 Radial Versus Femoral Secondary Access for Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-AnalysisJournal of the American College of Cardiology
- 2019Lineage-specific events underlie aortic root aneurysm pathogenesis in Loeys-Dietz syndromeJournal of Clinical InvestigationRCR 4.1197 citesPMID 30614814
- 2019Epigenetic activation and memory at a <i>TGFB2</i> enhancer in systemic sclerosisScience Translational Medicinefirst authorRCR 2.1155 citesPMID 31217334
- 2019Targeting of dermal myofibroblasts through death receptor 5 arrests fibrosis in mouse models of sclerodermaNature CommunicationsRCR 1.7342 citesPMID 30850660
- 2019435 Epigenetic activation of a novel TGFβ2 enhancer sustains dermal fibrosis in systemic sclerosisJournal of Investigative Dermatologyfirst author
- 2019TARGETING FIBROSIS: THERAPEUTIC AND PATHOGENIC EPIGENETIC MODULATION OF A NOVEL TGFβ2 ENHANCER IN SYSTEMIC SCLEROSISfirst author
- 2017Study on the Role of Biochemical Fullerene Derivatives in Treating Tumor CellsBulletin of the American Physical Societysenior author
- 2015Single-Cell RNA-Seq with Waterfall Reveals Molecular Cascades underlying Adult NeurogenesisCell stem cellRCR 16.02600 citesPMID 26299571
- 2015A Case Series: Exercise-Induced EsotropiaAmerican Orthoptic Journalfirst authorRCR 0.152 citesPMID 26564937
- 2014High c-Kit expression identifies hematopoietic stem cells with impaired self-renewal and megakaryocytic biasThe Journal of Experimental Medicinefirst authorRCR 5.01202 citesPMID 24446491
- 2014Anti-aging interventions reverse hematopoietic stem cell aging via regulation of micrornasExperimental Hematology
- 2013Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivoThe Journal of Experimental MedicineRCR 6.41284 citesPMID 24218140
- 2013
- 2008Acid-base interpretation as a predictor of outcome in acute organophosphate poisoningThe American Journal of Emergency Medicinefirst authorRCR 0.031 citesPMID 18606331
- 2006Extranodal Marginal Zone B-Cell Lymphoma/Maltoma of the Lip in a ChildInternational Journal of Surgical PathologyRCR 0.7118 citesPMID 16703182
- 2002Suppressive effects of ansamycins on inducible nitric oxide synthase expression and the development of experimental autoimmune encephalomyelitisJournal of Neuroscience ResearchRCR 0.6029 citesPMID 11835313
Compiled from public program rosters and open scholarly data (PubMed, OpenAlex, ORCID) with field-normalized impact (NIH iCite RCR). Publication attribution is being actively improved; counts shown are conservative.